Polaris Market Research today announced findings from its latest report, projecting the global branded generics market to grow from USD 265.9 billion in 2024 to USD 410.86 billion by 2032, registering a CAGR of 5.6% during the forecast period. The market is being shaped by the rising prevalence of chronic diseases, increasing demand for affordable medicines, patent expirations, government...

In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...

 The global branded generics market is projected to increase from USD 414.5 billion in 2026 to USD 928.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 8.4%, according to Future Market Insights (FMI). The market is benefiting from sustained demand for affordable prescription medicines, particularly in chronic disease management, alongside physician familiarity with...

Polylactic Acid Market to Hit USD 3,665.79 million by 2032, Growing at 19.40% CAGR: Polaris Market Research Polaris Market Research highlights findings from its Polylactic Acid Market report, which values the market at USD 889.82 million in 2024 and projects it to reach USD 3,665.79 million by 2032, expanding at a CAGR of 19.40% during 2024-2032. The report evaluates competitive positioning and...